Showing results (1-10 of 632) with videos related to
Sort By:
Pageof 64
Lancet (London, England)|April 2, 1994
Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)K L Woods, S FletcherBritish Heart Journal|November 1, 1992
Modification of the circadian rhythm of onset of acute myocardial infarction by long-term antianginal treatmentK L Woods, S Fletcher, C JaggerBritish Heart Journal|February 1, 1994
Investigation of the effects of intravenous magnesium sulphate on cardiac rhythm in acute myocardial infarctionC Roffe, S Fletcher, K L WoodsLancet (London, England)|June 27, 1992
Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)K L Woods, S Fletcher, C Roffe, et al.Clinical Science (London, England : 1979)|January 15, 2002
T-ceIl recognition of discrete regions of the thrombolytic drug streptokinaseW J Lawley, S Fletcher, I B Squire, et al.BMJ (Clinical Research Ed.)|March 1, 1997
First myocardial infarction in patients of Indian subcontinent and European origin: comparison of risk factors, management, and long term outcomeN Shaukat, J Lear, A Lowy, et al.European Heart Journal|August 24, 1999
Humoral and cellular immune responses up to 7.5 years after administration of streptokinase for acute myocardial infarctionI B Squire, W Lawley, S Fletcher, et al.Lancet (London, England)|September 2, 1995
Mega-trials and management of acute myocardial infarctionK L WoodsJournal of Clinical and Hospital Pharmacy|February 1, 1986
The mode of action of cardiac glycosidesK L WoodsDrugs & Aging|January 12, 1999
Utilisation of thrombolytic therapy in older patients with myocardial infarctionK L Woods, D KetleyPageof 64